JMP Securities Maintains Market Outperform on OrthoPediatrics, Lowers Price Target to $50
Portfolio Pulse from Benzinga Newsdesk
JMP Securities analyst David Turkaly has maintained a Market Outperform rating on OrthoPediatrics (NASDAQ:KIDS) but has reduced the price target from $60 to $50.
December 07, 2023 | 6:18 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
JMP Securities reaffirmed a Market Outperform rating for OrthoPediatrics but lowered the price target from $60 to $50.
The reduction in price target by JMP Securities, despite maintaining a positive Market Outperform rating, could lead to a negative short-term sentiment among investors, potentially causing a decrease in the stock price of OrthoPediatrics.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100